A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,199 shares of PLRX stock, worth $27,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,199
Previous 1,801 22.1%
Holding current value
$27,993
Previous $19,000 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$10.52 - $14.35 $4,186 - $5,711
398 Added 22.1%
2,199 $24,000
Q2 2024

Jul 30, 2024

BUY
$10.58 - $15.61 $19,054 - $28,113
1,801 New
1,801 $19,000
Q4 2023

Jan 24, 2024

BUY
$12.85 - $19.15 $1,143 - $1,704
89 Added 0.33%
27,363 $495,000
Q3 2023

Oct 26, 2023

BUY
$14.58 - $20.15 $1,006 - $1,390
69 Added 0.25%
27,274 $472,000
Q2 2023

Aug 10, 2023

BUY
$18.12 - $30.56 $492,954 - $831,384
27,205 New
27,205 $492,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $620M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.